News
IART
11.26
+3.49%
0.38
Integra LifeSciences Files Initial Beneficial Ownership Statement for Michael Damon Hutchinson, EVP and Chief Legal Officer
Reuters · 4d ago
Piper Sandler Appoints Stuart Essig to Board of Directors
Reuters · 4d ago
Piper Sandler Companies beruft Stuart M. Essig in den Vorstand
Reuters · 4d ago
Weekly Report: what happened at IART last week (0126-0130)?
Weekly Report · 6d ago
Is It Time To Consider Buying Integra LifeSciences Holdings Corporation (NASDAQ:IART)?
Simply Wall St · 01/29 13:34
BTIG Keeps Their Hold Rating on Integra Lifesciences (IART)
TipRanks · 01/27 13:16
Weekly Report: what happened at IART last week (0119-0123)?
Weekly Report · 01/26 10:15
FDA Issues Alert For Integra Wound Care Products Over Infection Fears
Benzinga · 01/23 17:22
JPMorgan’s top short ideas for Q1: FTNT, TXT, IMO and more
Seeking Alpha · 01/23 16:24
FDA aware of Integra recommending removal of MediHoney and Burn products
TipRanks · 01/23 11:05
Correction: FDA aware of Integra recommending removal of MediHoney Wound
TipRanks · 01/23 10:45
Integra LifeSciences Identifies Issues With Wound, Burn Products
Dow Jones · 01/22 20:09
FDA aware of Integra recommending removal of MediWound, CVS Wound Gel products
TipRanks · 01/22 19:20
FDA Says Integra Lifesciences Identified Packaging Failures Related To MediHoney Wound & Burn Products That Could Lead To A Breach In The Sterile Barrier; Integra Lifesciences Identified Production And Process Control Issues For Certain CVS Wound Gel Products; As Of December 19, 2025, Integra Lifesciences Has Reported 11 Serious Injuries Related To MediHoney Wound And Burn Products, Has Reported 3 Serious Injuries Related To CVS Wound Gel Products; Reported No Deaths Associated
Benzinga · 01/22 17:44
FDA:AS OF DECEMBER 19, 2025, INTEGRA LIFESCIENCES HAS REPORTED NO DEATHS ASSOCIATED WITH MEDIHONEY WOUND AND BURN PRODUCTS & CVS WOUND GEL PRODUCTS
Reuters · 01/22 17:39
Weekly Report: what happened at IART last week (0112-0116)?
Weekly Report · 01/19 10:21
3 Undervalued Medical Instrument Stocks Poised to Grow in 2026
NASDAQ · 01/16 14:27
Integra LifeSciences Showcases Growth Strategy and Innovation Focus in Latest Investor Presentation
Reuters · 01/14 18:58
Weekly Report: what happened at IART last week (0105-0109)?
Weekly Report · 01/12 10:20
Undervalued Small Caps With Insider Activity To Watch In January 2026
Simply Wall St · 01/08 11:09
More
Webull provides a variety of real-time IART stock news. You can receive the latest news about Integra Lifesciences Hldgs Cp through multiple platforms. This information may help you make smarter investment decisions.
About IART
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.